Fortrea Holdings (FTRE) Divestments (2024 - 2025)

Fortrea Holdings (FTRE) reported Divestments of $20.6 million for Q3 2025, up 339.53% on a YoY basis from $4.7 million in Q3 2024, and up 8.42% quarter-over-quarter from $19.0 million in Q1 2025.

Fortrea Holdings (FTRE) Divestments (2024 - 2025) Analysis & Trends

Fortrea Holdings has reported Divestments for 2 years, with the latest figure at $20.6 million in Q3 2025.

  • For the quarter ending Q3 2025, Divestments rose 339.53% year-over-year to $20.6 million; the trailing twelve-month figure through Mar 2026 stood at $20.6 million (down 93.03% YoY), and the FY2025 full-year result was $39.6 million, down 85.68% from the prior year.
  • Divestments for Q3 2025 stood at $20.6 million, up from $19.0 million in the prior quarter.
  • The five-year high for Divestments was $285.2 million in Q2 2024, with the low at -$8.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 20.60 Mn
Mar 31, 2025 19.00 Mn
Sep 30, 2024 -8.60 Mn
Jun 30, 2024 285.20 Mn